Health

The Adecco Group: Q3 2024 RESULTS

Robust performance in challenging markets; volumes stabilising ZURICH, Nov. 5, 2024 /PRNewswire/ -- * Revenues -5% yoy organic TDA, -3% yoy organic, a solid result given market conditions, high comparison base; volumes stabilising * By GBU, Adecco -5%, with good results across Asia, Iberia, E...

2024-11-05 13:45 1183

Ping An Selected on Forbes' "World's Best Employer 2024" List, 2nd among China's Financial Companies

HONG KONG and SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) climbed 29 spots to 318th on Forbes World's Best Employers 2024 list. It ranked #2 amongChina's financial compa...

2024-11-04 18:16 2131

Embrace Autumn Outdoor Activities: Renowned Traditional Chinese Medicine Expert Professor Tinly Wong Tin-Chee Offers Effective Solutions for Relieving Post-Exercise Muscle Soreness with Massage, Herbal Oils, and Plasters

HONG KONG, Nov. 4, 2024 /PRNewswire/ -- As autumn settles in and temperatures begin to drop, many individuals embrace outdoor activities such as running, cycling, and hiking, delighting in the beauty of nature. However, post-exercise muscle soreness can become a common challenge for those who typ...

2024-11-04 09:00 3016

The world's first live sperm analyzer has been launched! The Basecare Medical-B (2170. HK) intelligent sperm analyzer is expected to replace the traditional CASA diagnostic mode!

SUZHOU, China, Nov. 4, 2024 /PRNewswire/ -- According to the latest data from the Maternal and Child Health Department of the Chinese National Health Commission, there are currently 602 medical institutions inChina that have been approved to carry out human assisted reproductive technology, and t...

2024-11-04 07:00 1940

Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals

MELBOURNE, Australia, Nov. 4, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes the announcement bythe United States (U.S.) Centers for Medicare & Medicaid Services (CMS) that it will pay separately for specialised diagnostic radiopharmaceuticals[1] ...

2024-11-04 06:07 1537

USANA Helps to Feed Australians in Need Through Donations and Service

SYDNEY, Nov. 4, 2024 /PRNewswire/ -- With community as one of USANA Health Science's core values, the company knows the importance of taking care of everyone inside and outside of the USANA family. USANA'sAustralia market took it upon themselves to help citizens that struggle with food insecurity...

2024-11-04 05:44 1755

Opening Ceremony of The 18th China (Chongqing) Elderly Industry Expo And The 5th China (Chongqing) Big Health Industry Expo

CHONGQING, China, Nov. 2, 2024 /PRNewswire/ -- A news report from iChongqing. The 18th China (Chongqing) Elderly Industry Expo and the 5th China (Chongqing ) Big Health Industry Expo, guided by the China Association for Social Welfare and Elderly Care Services and organized by multiple enterprises...

2024-11-02 15:49 3476

INTERNATIONAL ALLIED HEALTH CONFERENCE 2024: A GLOBAL PLATFORM FOR HEALTHCARE COLLABORATION

Singapore hosts landmark event uniting over 1,100 Allied Health Professionals and students from around the world SINGAPORE, Nov. 1, 2024 /PRNewswire/ -- The International Allied Health Conference (IAHC 2024), which was held in conjunction with the third Singapore Allied Health Conference on1 Nov...

2024-11-01 21:09 6152

DX&VX Selected for Korea's First ARPA-H Project in 2024, Focusing on Room Temperature and Extra-Long-Term Vaccine Storage Technology

* Pioneering Korea's ARPA-H Project: Focused on mRNA Vaccine Room-Temperature Storage and Extra-Long-Term Preservation * Creating a Platform for Prolonged Room-Temperature Storage and Efficient Distribution of mRNA Vaccines SEOUL, South Korea, Nov. 1, 2024 /PRNewswire/ -- OnOctober 30, a Ko...

2024-11-01 21:00 3567

The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024

WASHINGTON, Nov. 1, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, has just released the 1-year outcome of LuX-Valve Pl...

2024-11-01 21:00 1707

ICANN81 in Istanbul to Address Future of Global Internet Governance

ISTANBUL, Nov. 1, 2024 /PRNewswire/ -- The Internet Corporation for Assigned Names and Numbers (ICANN) will hold its 81st Public Meeting inIstanbul from 9-14 November 2024, hosted by the Information and Communication Technologies Authority (BTK). This event will bring together in-person and virtu...

2024-11-01 18:56 1630

National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment

International collaboration meets in Vietnam to facilitate treatment recommendation guidelines that help people with cancer to live better lives. HANOI, Vietnam, Nov. 1, 2024 /PRNewswire/ -- As part of ongoing work to define and advance high-quality cancer care globally, leaders from the National...

2024-11-01 10:04 2097

Zepp Health Launches Enhanced Zepp App 9: Elevating Personalized Health and Wellness for Amazfit Users Worldwide

MILPITAS, Calif., Oct. 31, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced the launch of the enhancedZepp App 9. This latest app version is designed to deliver a more personalized health, wellness...

2024-10-31 23:00 2746

Bridging Geographical Boundaries: Abrobo's Groundbreaking Contribution to China Medical Innovation-- the World's First Live Broadcast of Remote Cerebrovascular Interventional Operation on Animal at an Academic Conference

SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- This golden October, great minds gathered to embark on a new chapter of innovation. The 2024 Oriental Conference of Interventional Neurovascology (OCIN 2024), a premier event in neurovascular treatment, was held successfully fromOctober 25th to 27th at the ...

2024-10-31 22:54 8059

HKUST Spearheads Four Large AI Models to Revolutionize Healthcare

HONG KONG, Oct. 31, 2024 /PRNewswire/ -- In a groundbreaking initiative, The Hong Kong University of Science and Technology (HKUST) has unveiled four AI-driven models poised to transform the medical and healthcare fields. These AI models can assist both general and specialist medical practitioner...

2024-10-31 21:46 2106

CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK

* This approval marks the second international marketing authorization for sugemalimab outside ofChina, following its recent approval by the European Commission. * The approval is based on results from the Phase 3 GEMSTONE-302 clinical trial, which demonstrated that sugemalimab in combination...

2024-10-31 13:00 1872

Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC

CHENGDU, China, Oct. 31, 2024 /PRNewswire/ -- The new drug application (NDA) (the "Application") based on the positive results from the pivotal phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) developed by Sichuan Kelun-Biotech Biopharmaceutical Co., L...

2024-10-31 12:34 1553

Breakthrough Australian Cancer trial: retraining immune cells offers new hope for patients

ADELAIDE, Australia and BOSTON, Oct. 31, 2024 /PRNewswire/ -- In a remarkable development for cancer research, Australian patients with advanced-stage cancer have benefited from SUPLEXA, a personalised treatment that trains the patient's own immune cells to fight cancer. "Cancer often gains th...

2024-10-31 12:00 1659

RapidAI Applauded by Frost & Sullivan for Enhancing the Quality, Accuracy, and Speed of Stroke Imaging Diagnostics and Treatment, Demonstrating Its Market-leading Position

RapidAI's leadership is evident in its expansive global presence, pioneering regulatory achievements, and continuous innovation, ensuring the company remains at the forefront of AI-based imaging solutions. SAN ANTONIO, Oct. 31, 2024 /PRNewswire/ -- Recently Frost & Sullivan researched the AI-bas...

2024-10-31 01:50 1498

Latest Updates of Viva Biotech's Portfolio Companies

HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...

2024-10-30 22:24 1937
1 ... 45678910 ... 580